Biosafety and biocompatibility assessment of Prussian blue nanoparticles in vitro and in vivo

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Qin Z, Li Y, Gu N. Progress in applications of Prussian blue nanoparticles in biomedicine. Adv. Healthc. Mater. 7(20), e1800347 (2018).
  MedlineGoogle Scholar
• 2. Jia X, Cai X, Chen Y et al. Perfluoropentane-encapsulated hollow mesoporous Prussian blue nanocubes for activated ultrasound imaging and photothermal therapy of cancer. ACS Appl. Mater. 7(8), 4579–4588 (2015).
  Medline CASGoogle Scholar
• 3. Espinoza-Castañeda M, Escosura-Muñiz ADL, Chamorro A, Torres CD, Merkoçi A. Nanochannel array device operating through Prussian blue nanoparticles for sensitive label-free immunodetection of a cancer biomarker. Biosens. Bioelectron. 67, 107–114 (2015).
  Medline CASGoogle Scholar
• 4. Peng X, Wang R, Wang T et al. Carbon dots/Prussian blue satellite/core nanocomposites for optical imaging and photothermal therapy. ACS Appl. Mater. 10(1), 1084–1092 (2018).
  Medline CASGoogle Scholar
• 5. Zhu W, Liu K, Sun X et al. Mn²⁺-doped prussian blue nanocubes for bimodal imaging and photothermal therapy with enhanced performance. ACS Appl. Mater. 7(21), 11575–11582 (2015).
  Medline CASGoogle Scholar
• 6. Dacarro G, Taglietti A, Pallavicini P. Prussian blue nanoparticles as a versatile photothermal tool. Molecules 23(6), 1414 (2018).
  Google Scholar
• 7. Borzenkov M, D'alfonso L, Polissi A et al. Novel photo-thermally active polyvinyl alcohol-Prussian blue nanoparticles hydrogel films capable of eradicating bacteria and mitigating biofilms. Nanotechnology 30(29), 295702 (2019).
  Medline CASGoogle Scholar
• 8. Tong C, Zhong X, Yang Y et al. PB@PDA@Ag nanosystem for synergistically eradicating MRSA and accelerating diabetic wound healing assisted with laser irradiation. Biomaterials 243, 119936 (2020).
  Medline CASGoogle Scholar
• 9. Liu B, Wang W, Fan J et al. RBC membrane camouflaged Prussian blue nanoparticles for gamabutolin loading and combined chemo/photothermal therapy of breast cancer. Biomaterials 217, 119301 (2019).
  Medline CASGoogle Scholar
• 10. Zhao J, Cai X, Gao W et al. Prussian blue nanozyme with multienzyme activity reduces colitis in mice. ACS Appl. Mater. 10(31), 26108–26117 (2018).
  Medline CASGoogle Scholar
• 11. Liu Y, Shu G, Xue L, Chen H, Jin C. Human HSP70 promoter-based Prussian blue nanotheranostics for thermo-controlled gene therapy and synergistic photothermal ablation. Adv. Funct. Mater. 28(32), 1802026 (2018).
  Google Scholar
• 12. Shokouhimehr M, Soehnlen ES, Hao J et al. Dual purpose Prussian blue nanoparticles for cellular imaging and drug delivery: a new generation of T1-weighted MRI contrast and small molecule delivery agents. J. Mater. Chem. 20(25), 5251–5259 (2010).
  CASGoogle Scholar
• 13. Patra CR. Prussian blue nanoparticles and their analogues for application to cancer theranostics. Nanomedicine (Lond.) 11(6), 569–572 (2016).
  CASGoogle Scholar
• 14. Liu H, Wang X, Wu Y et al. Toxicity responses of different organs of zebrafish (Danio rerio) to silver nanoparticles with different particle sizes and surface coatings. Environ. Pollut. 246, 414–422 (2019).
  Medline CASGoogle Scholar
• 15. Feng Q, Liu Y, Huang J, Chen K, Huang J, Xiao K. Uptake, distribution, clearance and toxicity of iron oxide nanoparticles with different sizes and coatings. Sci. Rep. 8(1), 2082 (2018).
  MedlineGoogle Scholar
• 16. Wang X, Li X, Ito A, Sogo Y, Ohno T. Particle-size-dependent toxicity and immunogenic activity of mesoporous silica-based adjuvants for tumor immunotherapy. Acta Biomater. 9(7), 7480–7489 (2013). • Some widely used nanomaterials have shown toxicity related with to size, shape and charge.
  Medline CASGoogle Scholar
• 17. Javed I, Peng G, Xing Y et al. Inhibition of amyloid beta toxicity in zebrafish with a chaperone-gold nanoparticle dual strategy. Nat. Commun. 10(1), 3780 (2019).
  MedlineGoogle Scholar
• 18. Xiao F, Fan J, Tong C et al. An erythrocyte membrane coated mimetic nano-platform for chemo-phototherapy and multimodal imaging. RSC Adv. 9(48), 27911–27926 (2019).
  CASGoogle Scholar
• 19. Jia Z, Sun G. Preparation of Prussian blue nanoparticles with single precursor. Colloids Surf. A Physicochem. Eng. Asp. 302(1–3), 326–329 (2007).
  CASGoogle Scholar
• 20. Sugimoto T, Shiba F, Sekiguchi T, Itoh H. Spontaneous nucleation of monodisperse silver halide particles from homogeneous gelatin solution I: silver chloride. Colloids Surf. A Physicochem. Eng. Asp. 164(2–3), 183–203 (2000). •• Size control theory has been developed to offer a theoretical background for the size control of monodispersed particles in closed systems.
  CASGoogle Scholar
• 21. Fu G, Liu W, Feng S, Yue X. Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy. Chem. Commun. (Camb.) 48(94), 11567–11569 (2012). • Prussian blue nanoparticles have good catalase activity and this activity is determined by the structure.
  Medline CASGoogle Scholar
• 22. Kim H-M, Kim K-M, Lee K, Kim YS, Oh J-M. Nano-bio interaction between graphite oxide nanoparticles and human blood components. Eur. J. Inorg. Chem. 2012(32), 5343–5349 (2012).
  CASGoogle Scholar
• 23. Ding L, Yao C, Yin X et al. Size, Shape and protein corona determine cellular uptake and removal mechanisms of gold nanoparticles. Small 14(42), e1801451 (2018).
  MedlineGoogle Scholar
• 24. Mao Z, Liu Z, Chen L et al. Predictive value of the surface-enhanced resonance raman scattering-based MTT assay: a rapid and ultrasensitive method for cell viability in situ. Anal. Chem. 85(15), 7361–7368 (2013).
  Medline CASGoogle Scholar
• 25. Chen J, Wang Q, Huang L et al. Prussian blue with intrinsic heme-like structure as peroxidase mimic. Nano Res. 11(9), 4905–4913 (2018).
  CASGoogle Scholar
• 26. Ma H, He Y, Liu H et al. Anchoring of Prussian blue nanoparticles on polydopamine nanospheres as an efficient peroxidase mimetic for colorimetric sensing. Colloids Surf. A Physicochem. Eng. Asp. 577, 622–629 (2019).
  CASGoogle Scholar
• 27. Wu T, Hou W, Ma Z et al. Colorimetric determination of ascorbic acid and the activity of alkaline phosphatase based on the inhibition of the peroxidase-like activity of citric acid-capped Prussian Blue nanocubes. Mikrochim. Acta 186(2), 123 (2019).
  MedlineGoogle Scholar
• 28. Zhang X-Q, Gong S-W, Zhang Y, Yang T et al. Prussian blue modified iron oxide magnetic nanoparticles and their high peroxidase-like activity. J. Mater. Chem. 20(24), 5110 (2010).
  CASGoogle Scholar
• 29. Li J, Zhang X, Jiang J et al. Systematic assessment of the toxicity and potential mechanism of graphene derivatives in vitro and in vivo. Toxicol. Sci. 167(1), 269–281 (2019).
  Medline CASGoogle Scholar
• 30. Sohaebuddin SK, Thevenot PT, Baker D et al. Nanomaterial cytotoxicity is composition, size and cell type dependent, part. Part. Fibre Toxicol. 7(7), 22 (2010).
  MedlineGoogle Scholar
• 31. Zhang X, Zhang Z, Zhang S et al. Size effect on the cytotoxicity of layered black phosphorus and underlying mechanisms. Small 13(32), 1701210 (2017).
  Google Scholar
• 32. Yang L, Kuang H, Zhang W et al. Size dependent biodistribution and toxicokinetics of iron oxide magnetic nanoparticles in mice. Nanoscale 7(2), 625–636 (2015).
  Medline CASGoogle Scholar
• 33. Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 33(9), 941–951 (2015). • Prussian blue-like substance shows size-dependent biodistribution.
  Medline CASGoogle Scholar
• 34. Anderson FH, Zeng LC, Rock NR, Yoshida EM. An assessment of the clinical utility of serum ALT and AST in chronic hepatitis C. Hepatol. Res. 18(1), 63–71 (2000).
  Medline CASGoogle Scholar
• 35. Balbaied T, Moore E. Overview of optical and electrochemical alkaline phosphatase (ALP) biosensors: recent approaches in cells culture techniques. Biosensors (Basel) 9(3), (2019).
  MedlineGoogle Scholar
• 36. Uchino Shigehiko. Creatinine. Curr. Opin. Crit. Care 16(6), 562–567 (2010).
  MedlineGoogle Scholar
• 37. Aizawa T, Hiramatsu K, Ohtsuka H et al. An elevation of BUN/creatinine ratio in patients with hyperthyroidism. Horm. Metab. Res. 18(11), 771–774 (1986).
  Medline CASGoogle Scholar